Weight Often Returns Within Two Years After Stopping GLP‑1 Drugs, Study Finds
A University of Oxford study found people regain about 0.9 pounds monthly and return to baseline weight within two years after stopping GLP‑1 weight‑loss medications.
FOX NewsWeight-loss experts predict 5 major treatment changes likely to emerge in 2026
Scientific AmericanThe Weight-Loss Drug Revolution—Shots, Pills and the Science behind the Hype
NewsmaxStudy: Weight Often Returns After Stopping Ozempic
Scientific AmericanWeight and Health Benefits Vanish Fast after Quitting Weight-Loss Drugs, Study Finds
Overview
University of Oxford analysis in The BMJ reports people stopping GLP‑1 drugs regain weight averaging 0.9 pounds per month, typically returning to pre-treatment weight within two years.
Weight regained after ceasing GLP‑1 therapy occurs about four times faster than weight regained following discontinued diet and exercise programs, the study found.
GLP‑1 medicines such as Ozempic and Wegovy have drastically improved obesity treatment effectiveness by producing significant weight loss while in active use.
Stopping GLP‑1 medications also reverses related health benefits — including reductions in weight and cardiovascular risk — often within two years after discontinuation.
The findings suggest long-term treatment or maintenance strategies may be necessary to preserve weight loss benefits, raising questions about therapy duration and cost.
Analysis
Center-leaning sources frame the story by emphasizing the scientific findings and expert opinions, highlighting the challenges of maintaining weight loss with GLP-1 drugs. They use neutral language, focusing on the data and expert quotes to present a balanced view. The narrative underscores the chronic nature of obesity and the need for comprehensive weight management strategies, avoiding sensationalism or blame.